Valuation: Ind-Swift Laboratories Limited

Market Cap 11.4B 119M 104M 97M 88.47M 166M 169M 1.14B 446M 5.71B 449M 439M 19.03B P/E 2024
1.41x
P/E 2025 2.38x
Enterprise Value 7.13B 74.77M 64.78M 60.69M 55.36M 104M 106M 714M 279M 3.57B 281M 275M 11.91B EV / Sales 2024
0.14x
EV / Sales 2025 0.12x
Free-Float
40.72%
Yield 2024 *
-
Yield 2025 -
1 day+5.38%
1 week+30.32%
Current month+33.77%
1 month+21.73%
3 months+116.54%
6 months+125.45%
Current year+240.33%
1 week 225
Extreme 225
320.5
1 month 215
Extreme 215
320.5
Current year 87.25
Extreme 87.25
320.5
1 year 87.15
Extreme 87.15
320.5
3 years 68.72
Extreme 68.72
320.5
5 years 52.65
Extreme 52.65
320.5
10 years 15
Extreme 15
320.5
Manager TitleAgeSince
Chief Executive Officer 74 03/01/1995
Chief Executive Officer 44 14/06/2011
Director of Finance/CFO - 28/09/2018
Director TitleAgeSince
Director/Board Member 44 -
Chairman 74 -
Director/Board Member 35 22/03/2010
Date Insider Type Main position Quantity % Market Cap.
12/09/24 Sell

Chief Financial Officer

30,000 0.0508%
Change 5-day change 1-year change 3-year change Capi.($)
+5.38%+30.32%+189.27%+221.89% 260M
+0.10%-1.02%+20.87%+71.68% 48.85B
-2.47%+1.96%+56.83%+119.26% 41.43B
+1.18%+6.64%+26.11%+85.11% 12.46B
0.00%+0.21%-2.78%+17.02% 12.39B
+0.96%-0.57%+30.73%+135.91% 9.08B
-0.08%+7.60%+24.69%+40.11% 7.53B
-0.12%+4.72%+41.49%-13.56% 7.14B
+0.62%+2.92%+11.75%+185.77% 6.73B
-0.87%+3.55%-25.69%+28.51% 5.88B
Average +0.47%+5.63%+37.33%+89.17% 15.18B
Weighted average by Cap. -0.49%+3.53%+29.01%+83.23%

Financials

2024 2025
Net sales 12.97B 136M 118M 110M 101M 189M 192M 1.3B 508M 6.5B 511M 500M 21.66B 5.62B 58.89M 51.02M 47.81M 43.61M 81.98M 83.24M 562M 220M 2.81B 221M 216M 9.38B
Net income 4.21B 44.14M 38.24M 35.83M 32.68M 61.44M 62.38M 421M 165M 2.11B 166M 162M 7.03B 2.5B 26.26M 22.75M 21.32M 19.44M 36.56M 37.12M 251M 98.01M 1.25B 98.6M 96.46M 4.18B
Net Debt -4.15B -43.54M -37.73M -35.35M -32.24M -60.61M -61.54M -416M -163M -2.08B -163M -160M -6.93B -4.27B -44.72M -38.75M -36.3M -33.11M -62.25M -63.21M -427M -167M -2.14B -168M -164M -7.12B
Logo Ind-Swift Laboratories Limited
Ind-Swift Laboratories Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (APIs), intermediates and formulations. The Company operates in the Pharmaceutical Business segment. It also focuses on manufacturing formulations. The Company’s products include APIs and Impurities. Its APIs therapeutic category includes Macrolide Antibiotic, Cardiovascular, Antihistaminic, Antidiabetic, Antipsyhotic, Bone Resorption Inhibitor, and Aromatase Inhibitor. Its products include Clarithromycin, Clarithromycin Coated Granules, Clarithromycin Citrate, Atorvastatin Calcium Crystalline, Atorvastatin Calcium Amorphous, Clopidogrel HCl, Ezetimibe, Ivabradine Oxalate, Ranolazine, Aripiprazole, Risedronate Sodium, Ropinirole HCl, Cinacalcet HCl, Letrozole, and Anastrozole. Its products under development include Sitagliptin Phosphate, Mirabegron, Bempedoic Acid, Lasmiditan, and Eltrombopag Olamine.
Employees
1,246
Date Price Change Volume
12/08/26 300.00 +5.38% 8,635,452
11/08/26 ₹284.68 +20.00% 9,123,251
10/08/26 ₹237.24 +3.87% 1,031,876
07/08/26 ₹228.41 +0.85% 277,067
06/08/26 ₹226.48 -1.71% 324,739
  1. Stock Market
  2. Stocks
  3. INDSWFTLAB Stock